Sanofi India Q1 net profit down 8 percent to Rs 85.4 crores
New Delhi: Drug firm Sanofi India on Tuesday reported 8 per cent decline in its net profit to Rs 85.4 crore for the first quarter ended March 31, 2020.
The company had posted a net profit of Rs 92.9 crore for the same period previous fiscal, Sanofi India said in a regulatory filing.
The company follows a January-December financial year.
Revenue from operations of the company stood at Rs 784.5 crore for the quarter under consideration. It was Rs 717.3 crore for the same period a year ago, it added.
Shares of Sanofi India closed at Rs 7,469.20 per scrip on BSE, down 0.09 per cent from its previous close.
Read also: Sanofi gets USFDA priority review for sutimlimab for Hemolysis
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd